LIGABUE, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 9.020
EU - Europa 8.106
AS - Asia 4.569
SA - Sud America 578
Continente sconosciuto - Info sul continente non disponibili 148
AF - Africa 123
OC - Oceania 14
Totale 22.558
Nazione #
US - Stati Uniti d'America 8.781
IT - Italia 4.859
SG - Singapore 1.344
CN - Cina 1.253
DE - Germania 810
GB - Regno Unito 766
VN - Vietnam 512
HK - Hong Kong 479
BR - Brasile 420
SE - Svezia 373
RU - Federazione Russa 280
BD - Bangladesh 257
NL - Olanda 209
FR - Francia 199
FI - Finlandia 172
KR - Corea 149
CA - Canada 128
IN - India 114
TR - Turchia 92
ID - Indonesia 85
UA - Ucraina 84
AR - Argentina 61
MX - Messico 57
BG - Bulgaria 53
JP - Giappone 48
ES - Italia 44
IQ - Iraq 37
PL - Polonia 32
ZA - Sudafrica 32
CH - Svizzera 29
PK - Pakistan 27
MA - Marocco 26
BE - Belgio 23
CZ - Repubblica Ceca 22
MY - Malesia 22
AT - Austria 19
IE - Irlanda 19
IR - Iran 19
EC - Ecuador 18
VE - Venezuela 18
AE - Emirati Arabi Uniti 16
CO - Colombia 16
LT - Lituania 16
CL - Cile 15
PE - Perù 14
PT - Portogallo 13
UZ - Uzbekistan 13
AU - Australia 12
IL - Israele 12
RO - Romania 12
AZ - Azerbaigian 11
CR - Costa Rica 11
DZ - Algeria 11
EG - Egitto 11
KE - Kenya 10
PH - Filippine 10
TW - Taiwan 10
AL - Albania 9
JM - Giamaica 9
PY - Paraguay 9
SA - Arabia Saudita 9
TN - Tunisia 9
DK - Danimarca 8
DO - Repubblica Dominicana 8
JO - Giordania 8
MT - Malta 8
SI - Slovenia 8
BY - Bielorussia 7
KZ - Kazakistan 7
NO - Norvegia 6
NP - Nepal 6
PA - Panama 6
NG - Nigeria 5
RS - Serbia 5
TT - Trinidad e Tobago 5
GR - Grecia 4
HR - Croazia 4
MD - Moldavia 4
OM - Oman 4
BB - Barbados 3
BH - Bahrain 3
BO - Bolivia 3
GE - Georgia 3
GT - Guatemala 3
KH - Cambogia 3
NI - Nicaragua 3
SC - Seychelles 3
TH - Thailandia 3
UY - Uruguay 3
EU - Europa 2
HN - Honduras 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
MC - Monaco 2
MK - Macedonia 2
MZ - Mozambico 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SN - Senegal 2
Totale 22.385
Città #
Ashburn 892
Singapore 867
Santa Clara 784
San Jose 574
Fairfield 548
Hong Kong 462
Southend 459
Milan 442
Hefei 428
Chandler 392
Council Bluffs 358
Rome 328
Woodbridge 291
Houston 261
Seattle 215
Cambridge 205
Wilmington 205
Beijing 203
Nyköping 187
Ann Arbor 168
London 167
Ho Chi Minh City 162
Naples 151
Jacksonville 146
New York 145
Los Angeles 142
Seoul 139
Dearborn 133
Hanoi 126
Modena 121
Helsinki 116
Dallas 97
Bologna 90
The Dalles 89
Bari 74
Munich 73
Turin 72
Florence 68
Chicago 64
Frankfurt am Main 63
Lauterbourg 62
Buffalo 57
Jakarta 53
Moscow 53
San Diego 51
Parma 49
São Paulo 49
Princeton 47
Sofia 47
Catania 45
Orem 44
Shanghai 44
Izmir 39
Palermo 39
Phoenix 39
Tokyo 36
Genoa 35
Atlanta 34
Columbus 33
Toronto 33
Brescia 32
Eugene 32
Fremont 32
Verona 32
Montreal 30
Nuremberg 30
Des Moines 29
Redwood City 29
Reggio Emilia 29
Denver 25
Padova 25
Warsaw 25
Boardman 24
Falls Church 24
Guangzhou 24
Cagliari 23
Kent 22
Brooklyn 21
Da Nang 21
Lucca 21
Salerno 21
Livorno 20
Monza 20
Turku 20
Mexico City 19
Salt Lake City 19
Durham 18
Venice 18
Amsterdam 17
Bremen 17
Baghdad 16
Brussels 16
Haiphong 16
Perugia 16
Poplar 16
Tampa 16
Chennai 15
Norwalk 15
Wuhan 15
Dublin 14
Totale 12.270
Nome #
Effetto della N-acetilcisteina sulla progressione dell'insufficienza renale cronica nel ratto 4.331
The Role of PEC Progenitors in ADPKD Progression 1.111
Clinical outcome of kidney transplantation in HIV-infected recipients: a retrospective study 441
Identification and Characterization of New Proteins in Podocyte Dysfunction of Membranous Nephropathy by Proteomic Analysis of Renal Biopsy 426
CD133 and CD24 expression in renal tissue of patients affected by autosomal dominant polcystic kidney disease 421
Interstitial fluid obtained from kidney biopsy as new source of renal biomarkers 407
Activation of coagulation during hemodialysis: Effect of blood lines alone and whole extracorporeal circuit 389
Evaluation of a system for sorbent-assisted peritoneal dialysis in a uremic pig model 381
The prevalence of autosomal dominant polycystic kidney disease (ADPKD): A meta-analysis of European literature and prevalence evaluation in the Italian province of Modena suggest that ADPKD is a rare and underdiagnosed condition 374
Rhodococcus equi Pneumonia in Kidney Transplant Recipient Affected by Acute Intermittent Porphyria: A Case Report 373
Evaluation of the Classification Accuracy of the Kidney Biopsy Direct Immunofluorescence through Convolutional Neural Networks 368
GREASE II. A phase II randomized, 12-month, parallel-group, superiority study to evaluate the efficacy of a Modified Atkins Diet in Autosomal Dominant Polycystic Kidney Disease patients 363
Automated Prediction of Kidney Failure in IgA Nephropathy with Deep Learning from Biopsy Images 361
Identification and characterization of a new autoimmune protein in membranous nephropathy by immunoscreening of a renal cDNA library 361
P-Cresol and Cardiovascular Risk in Kidney Transplant Recipients 358
Confidence Calibration for Deep Renal Biopsy Immunofluorescence Image Classification 358
Immunophenotypic Profile and Clinical Outcome of Monoclonal B-cell Lymphocytosis in Kidney Transplantation 340
Efficacy of Belimumab for active lupus nephritis in a young Hispanic woman intolerant to standard treatment: a case report 333
A functionally active RAR alpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines 328
Il rene policistico autosomico dominante (ADPKD): aspetti genetico-molecolari, clinici ed epidemiologici nella provincia di Modena. 301
[Dyslipidemia and the risk of kidney disease]. 299
I polimorfismi del gene dell’enzima di conversione dell’angiotensina (ACE) nel rene policistico autosomico dominante (ADPKD) 293
Water treatment and monitor disinfection 291
Relapse of atypical hemolytic uremic syndrome during pregnancy in a patient on eculizumab maintenance treatment: A case report 285
Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease 283
A validated model of disease progression in IgA nephropathy 276
Proteomic analysis of urine from proteinuric patients shows a proteolitic activity directed against albumin 276
Assessing middle-molecular and protein-bound uremic toxins: a six month study of ATA vs PS membranes in hemodiafiltration 275
Acid base disorders in patients with COVID-19 275
#5187 GREASE II: A PHASE II RANDOMIZED, 24-MONTH, PARALLEL-GROUP, SUPERIORITY STUDY TO EVALUATE THE EFFICACY OF A KETOGENIC DIET IN ADPKD PATIENTS 268
In vitro efficacy and safety of a system for sorbent-assisted peritoneal dialysis 266
Detection of predictive urinary biomarkers of nephropathy in type 1 and type 2 diabetes by proteomic analysis 259
Epidermal growth factor receptor polymorphism and autosomal dominant polycystic kidney disease 258
Post-transplant recurrence of glomerulonephritis: a complex clinical case. 249
COVID-19 Rapid Antigen Test Screening in Patients on Hemodialysis 246
Interstitiome: a novel proteomic discipline applied to renal biopsy 245
Screening of a kidney cDNA library for the identification of autoimmune proteins from serum of membranous nephropathy patients. 245
Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19 244
The underlying cause of kidney disease is often unknown in dialysis patients: a possible genomic approach 242
FP808EARLY IDENTIFICATION OF SICKLE CELL NEPHROPATHY IN A COHORT OF CHILDREN WITH SICKLE CELL DISEASE 241
Screening of a kidney cDNA library for the identification of autoimmune proteins from serum of membranous nephropathy patients. 238
Influence of dialysate temperature on creatinine peritoneal clearance in peritoneal dialysis patients: a randomized trial 237
P-cresolo solfato e rischio cardiovascolare nel paziente trapiantato 236
Combining telemedicine and in-person visits to deliver care to patients with severe chronic kidney disease (CKD): Lessons learned from COVID-19 225
Clinical Predictors of Nondiabetic Kidney Disease in Patients with Diabetes: A Single-Center Study 220
Risk of bleeding after percutaneous native kidney biopsy in patients receiving low-dose aspirin: a single-center retrospective study 217
Immunosuppressive therapy reduction and early post-infection graft function in kidney transplant recipients with COVID-19 209
Weekly Rapid Antigen Test Screening for COVID-19 in Patients on Hemodialysis 204
Risk of infections related to endovascular catheters and cardiac implantable devices in hemodialysis patients 200
AKI in hospitalized patients with COVID-19: a single-center experience 192
Prolonged RT-PCR test positivity in hemodialysis patients with COVID-19 184
Reversed high-flux SUPRA HFR: a proof of concept pilot study to access the middle molecular weight uremic toxins 182
Rethinking Chronic Kidney Disease in the Aging Population 180
Towards the monitoring of dialysis treatment through absorption and endogenous fluorescence techniques 159
Reactogenicity of COVID-19 vaccine in hemodialysis patients: a single-center retrospective study 153
Il centro dialisi ecosostenibile 152
Seroconversion after COVID-19 vaccine in a dialysis patient on immunosuppressants 149
Middle-Molecular Weight Toxin Removal: Asymmetric Cellulose Triacetate vs. Helicoidal Polysulfone during Online Hemodiafiltration (CHORALS Study) 145
Screening for nasal carriage of Staphylococcus (S.) aureus reduces the risk of S. aureus peritonitis in patients on peritoneal dialysis (PD) 142
Rationale and design of the CORDIAL first-in-human clinical trial: a system for sorbent-assisted continuous flow peritoneal dialysis 139
Prevalence, clinical course and outcomes of COVID-19 in peritoneal dialysis (PD) patients: a single-center experience 133
Improving the sustainability and quality of kidney health care through life cycle assessments, quality improvement, education and technical innovations: the KitNewCare approach 130
Migrants on hemodialysis (HD): clinical characteristics, outcome and quality of life 126
Long-term mortality and technique survival in peritoneal dialysis patients: a 25-year retrospective analysis in a single center 121
Formative usability test of a novel device for peritoneal dialysis (WEAKID) 107
Diagnostic Yield and Clinical Impact of a Small Genetic Panel for Kidney Disease: A Multicenter, Retrospective European Study 105
Intradialytic clearances and reduction ratios for middle molecular weight uremic toxins and protein-bound uremic toxins: comparison of hemodiafiltration with asymmetric cellulose triacetate vs hemodiafiltration with helycoidal polysulfone during a 6-month follow-up 98
A life cycle assessment of peritoneal dialysis procurement in Italy: environmental burden and opportunities for improvement 94
Validation of Hemoglobin and Hematocrit Measurements from a Dialysis Machine Sensor Compared to Laboratory Analysis: A Cross-Sectional Study 93
Sustainable kidney care: A life cycle assessment of the peritoneal dialysis pathways 63
Rationale and design of the CORDIAL first-in-human clinical trial: A system for sorbent-assisted continuous flow peritoneal dialysis 50
Comparing environmental footprints of haemodialysis and online haemodiafiltration in Italy 44
#2314 Greenhouse gas emissions from the special waste incineration: a comparative analysis between a large Dialysis Center and a University Hospital 38
Green haemodialysis: comparison of dialysis bags versus fresenius granumix at the AOU Policlinico di Modena, Italy 37
Twelve-Month Evaluation of Middle Molecule (MMUT) and Protein-Bound Uremic Toxin (PBUT) Removal with Two Different Hemodiafiltration Filters 35
Theoretically redesigning peritoneal dialysis products for sustainability: A life cycle inventory approach 32
Continuous Flow Peritoneal Dialysis 25
Genomic Approaches for Monogenic Kidney Diseases: A Comparative Review of Diagnostic Methods and Precision Medicine Implications 15
Environmental footprint of peritoneal dialysis in Europe: a comparative life cycle assessment across four European centres 8
Totale 22.558
Categoria #
all - tutte 72.195
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.195


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022953 0 0 65 110 50 98 53 54 107 77 213 126
2022/20231.981 126 173 94 171 168 274 136 216 189 113 179 142
2023/20242.501 111 118 200 244 291 246 302 255 119 181 201 233
2024/20254.429 245 232 230 345 624 605 401 281 435 202 375 454
2025/20267.454 454 295 498 694 828 383 864 334 680 699 1.422 303
2026/20271.167 455 592 120 0 0 0 0 0 0 0 0 0
Totale 22.558